McIlrath & Eck’s Qiagen QGEN Stock Holding History

McIlrath & Eck’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.44K	Buy	+61	New	+$2.89K	﹤0.01%	1391
2025 Q4	–	Sell	-65	Closed	-$2.9K	–	1009
2025 Q3	$2.9K	Hold	65	–	–	﹤0.01%	812
2025 Q2	$3.12K	Hold	65	–	–	﹤0.01%	787
2025 Q1	$2.61K	Buy	+65	New	+$2.73K	﹤0.01%	805
2024 Q4	–	Sell	-65	Closed	-$3.05K	–	1015
2024 Q3	$3.05K	Hold	65	–	–	﹤0.01%	823
2024 Q2	$2.75K	Hold	65	–	–	﹤0.01%	793
2024 Q1	$2.88K	Sell	65 -1	-2%	-$46	﹤0.01%	791
2023 Q4	$3.04K	Hold	66	–	–	﹤0.01%	768
2023 Q3	$2.83K	Hold	66	–	–	﹤0.01%	741
2023 Q2	$3.15K	Hold	66	–	–	﹤0.01%	745
2023 Q1	$3.21K	Hold	66	–	–	﹤0.01%	731
2022 Q4	$3.49K	Hold	66	–	–	﹤0.01%	692
2022 Q3	$3K	Hold	66	–	–	﹤0.01%	724
2022 Q2	$3K	Hold	66	–	–	﹤0.01%	701
2022 Q1	$3K	Hold	66	–	–	﹤0.01%	706
2021 Q4	$4K	Hold	66	–	–	﹤0.01%	668
2021 Q3	$4K	Hold	66	–	–	﹤0.01%	663
2021 Q2	$3K	Hold	66	–	–	﹤0.01%	697
2021 Q1	$3K	Hold	66	–	–	﹤0.01%	666
2020 Q4	$4K	Buy	+66	New	+$3.52K	﹤0.01%	572

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McIlrath & Eck's QGEN Position: Q1 2026 in Review

McIlrath & Eck opened a new position in Qiagen (QGEN) in Q1 2026: 61 shares worth $2.44K. The stake represents ﹤0.01% of the portfolio and ranks #1391 among its holdings. This is a return to the name: McIlrath & Eck previously reported a position in QGEN as recently as Q3 2025.

McIlrath & Eck first reported a position in QGEN in Q4 2020 and has held it in 20 quarters since. The position peaked at $4K in Q4 2021. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

McIlrath & Eck held 61 shares of Qiagen worth $2.44K as of Q1 2026.
Qiagen was a new McIlrath & Eck position in Q1 2026.
Qiagen made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1391 holding.
McIlrath & Eck first reported a position in Qiagen in Q4 2020 and has held it in 20 quarters since.
McIlrath & Eck's Qiagen position peaked at $4K in Q4 2021.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.